Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-18 @ 6:28 AM
Study NCT ID:
NCT03076203
Status:
COMPLETED
Last Update Posted:
2025-04-29
First Post:
2017-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-21
First Submit QC Date:
None
Study First Post Date:
2017-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-28
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL